<DOC>
	<DOCNO>NCT02001714</DOCNO>
	<brief_summary>This three-site randomized control trial compare effectiveness cost-effectiveness group-administered behavioral treatment program treatment . Women stress , urgency , mixed urinary incontinence recruit screen centrally , evaluate clinically three study site , random assign one two treatment arm : 1 . Group behavioral treatment 2 . No treatment . Group treatment modality potential reach large population old woman urinary incontinence , traditional medical setting , also community setting . The investigator hypothesize group behavioral treatment effective treatment . The investigator hypothesize group treatment cost-effective compare treatment .</brief_summary>
	<brief_title>Group Learning Achieves Decreased Incidents Lower Urinary Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<mesh_term>Urinary Incontinence , Urge</mesh_term>
	<criteria>1 . Female 2 . Aged 55 year old 3 . Ability understand , read write English 4 . Stress , urgency , mixed urgency stress urinary incontinence ( UI ) ( self report ) 5 . On International Consultation Incontinence Modular Questionnaire Short Form ( ICIQ UISF ) , frequency leakage least 1 ( `` week less often '' ) item # 1 volume urine loss least 2 ( `` small amount '' ) item # 2 . 6 . Symptoms three month duration longer ( history ) 7 . Passing score ( i.e. , categorize `` probably demented '' ) MiniCog Test 8 . Timed `` Up Go '' Test ( TUG ) score 20 second less 9 . Willing undergo vaginal/pelvic examination 10 . Signed informed consent form 1 . History renal , bladder , uterine , ovarian , urethral , anal rectal cancer , radiation therapy pelvis cancer/malignancy , active cancer/malignancy ( except skin cancer ) 2 . Nonambulatory ( participant confine bed wheelchair ) 3 . Persistent pelvic pain ( define daily pelvic pain &gt; 3 month ) 4 . History neurologic endstage disease ( e.g . cerebral vascular accident ( CVA ) , Parkinson 's disease , multiple sclerosis , epilepsy , spinal cord tumor trauma , spina bifida , symptomatic herniated disc ) 5 . Previous treatment current participation research study UI , include surgery formal behavioral treatment ( pelvic floor muscle training , biofeedback , pelvic floor electrical stimulation , percutaneous tibial nerve stimulation , sacral neuromodulation , botox periurethral injection ) 6 . Currently take urinary incontinence overactive bladder medication 7 . History urinary condition procedure may affect continence status ( e.g . urethral diverticulum , previous augmentation cystoplasty artificial urinary sphincter ; implant nerve stimulators urinary symptom ) 8 . Participation drug/device research study . 9 . Pelvic organ prolapse protrude past introitus ( rest persist strain ) 10 . Evidence urinary tract infection ( UTI ) urine dipstick ( leukocytes +1 great , nitrite +1 great , leukocytes alone ( w/o nitrite ) +2 great , presence hematuria &gt; +1 ) . Participants may rescreened treatment antibiotic hematuria workup negative . 11 . History 2 recurrent UTI 's within past year ; one UTI within past 6 month 12 . Post void residual urine volume 150 cc . 13 . Unstable medical condition ( determine site PI )</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>